Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition

Infection and Immunity

Volumn 83, Issue 5, 2015, Pages 1749-1764

  Beatson, Scott A ^a   Ben Zakour, Nouri L ^a   Totsika, Makrina ^a,e   Forde, Brian M ^a   Watts, Rebecca E ^a,f   Mabbett, Amanda N ^a   Szubert, Jan M ^a   Sarkar, Sohinee ^a   Phan, Minh Duy ^a   Peters, Kate M ^a   Petty, Nicola K ^a,g   Alikhan, Nabil Fareed ^a   Sullivan, Mitchell J ^a   Gawthorne, Jayde A ^a   Stanton Cook, Mitchell ^a   Nhu, Nguyen Thi Khanh ^a   Chong, Teik Min ^b   Yin, Wai Fong ^b   Chan, Kok Gan ^b   Hancock, Viktoria ^c,h   Ussery, David W ^c,i   Ulett, Glen C ^a,d   Schembri, Mark A ^a   more..

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d GRIFFITH UNIVERSITY   (Australia)

^e QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^f QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^g UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^h Gambro AB   (Sweden)

ⁱ OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; AEROBACTIN; AFIMBRIAL ADHESIN; INTERLEUKIN 6; UNCLASSIFIED DRUG; BACTERIAL DNA;

ADULT; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASYMPTOMATIC BACTERIURIA; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA BASE COMPOSITION; DNA METHYLATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI K 12; ESCHERICHIA COLI VR50; EXTRACELLULAR MATRIX; FEMALE; GENE DELETION; GENE SEQUENCE; GENOMIC ISLAND; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; PROPHAGE; TYPE II SECRETION SYSTEM; URINARY TRACT INFECTION; ADAPTATION; ANIMAL; BACTERIUM ADHERENCE; BACTERIURIA; C57BL MOUSE; CASE REPORT; CELL LINE; CHEMISTRY; DNA SEQUENCE; EPITHELIUM CELL; GENETICS; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR EVOLUTION; MOLECULAR GENETICS; URINARY TRACT;

ADAPTATION, BIOLOGICAL; ADULT; ANIMALS; BACTERIAL ADHESION; BACTERIURIA; CARRIER STATE; CELL LINE; DNA, BACTERIAL; EPITHELIAL CELLS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; EVOLUTION, MOLECULAR; FEMALE; GENOME, BACTERIAL; HUMANS; MICE, INBRED C57BL; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; URINARY TRACT;

EID: 84928190191     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02810-14     Document Type: Article

References (96)

1. Foxman, B. 2002. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113(Suppl 1A):5S-13S. http://dx.doi.org/10.1016/S0002-9343(02)01054-9.
2. Dobrindt U, Agerer F, Michaelis K, Janka A, Buchrieser C, Samuelson M, Svanborg C, Gottschalk G, Karch H, Hacker J. 2003. Analysis of genome plasticity in pathogenic and commensal Escherichia coli isolates by use of DNA arrays. J Bacteriol 185:1831-1840. http://dx.doi.org/10.1128/JB.185.6.1831-1840.2003.
3. Dobrindt U, Hochhut B, Hentschel U, Hacker J. 2004. Genomic islands in pathogenic and environmental microorganisms. Nat Rev Microbiol 2:414-424. http://dx.doi.org/10.1038/nrmicro884.
4. Brzuszkiewicz E, Bruggemann H, Liesegang H, Emmerth M, Olschlager T, Nagy G, Albermann K, Wagner C, Buchrieser C, Emody L, Gottschalk G, Hacker J, Dobrindt U. 2006. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci U S A 103:12879-12884. http://dx.doi.org/10.1073/pnas.0603038103.
5. Klemm P, Schembri MA. 2000. Bacterial adhesins: function and structure. Int J Med Microbiol 290:27-35. http://dx.doi.org/10.1016/S1438-4221(00)80102-2.
6. Totsika M, Moriel DG, Idris A, Rogers BA, Wurpel DJ, Phan MD, Paterson DL, Schembri MA. 2012. Uropathogenic Escherichia coli mediated urinary tract infection. Curr Drug Targets 13:1386-1399. http://dx.doi.org/10.2174/138945012803530206.
7. Hannan TJ, Totsika M, Mansfield KJ, Moore KH, Schembri MA, Hultgren SJ. 2012. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev 36:616-648. http://dx.doi.org/10.1111/j.1574-6976.2012.00339.x.
8. Ulett GC, Totsika M, Schaale K, Carey AJ, Sweet MJ, Schembri MA. 2013. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr Opin Microbiol 16:100-107. http://dx.doi.org/10.1016/j.mib.2013.01.005.
9. Salvador E, Wagenlehner F, Kohler CD, Mellmann A, Hacker J, Svanborg C, Dobrindt U. 2012. Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes. Infect Immun 80:668-678. http://dx.doi.org/10.1128/IAI.06191-11.
10. Zdziarski J, Svanborg C, Wullt B, Hacker J, Dobrindt U. 2008. Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect Immun 76:695-703. http://dx.doi.org/10.1128/IAI.01215-07.
11. Plos K, Carter T, Hull S, Hull R, Svanborg Eden C. 1990. Frequency and organization of pap homologous DNA in relation to clinical origin of uropathogenic Escherichia coli. J Infect Dis 161:518-524. http://dx.doi.org/10.1093/infdis/161.3.518.
12. Mabbett AN, Ulett GC, Watts RE, Tree JJ, Totsika M, Ong CL, Wood JM, Monaghan W, Looke DF, Nimmo GR, Svanborg C, Schembri MA. 2009. Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol 299:53-63. http://dx.doi.org/10.1016/j.ijmm.2008.06.003.
13. Hull R, Rudy D, Donovan W, Svanborg C, Wieser I, Stewart C, Darouiche R. 2000. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J Urol 163:872-877. http://dx.doi.org/10.1016/S0022-5347(05)67823-8.
14. Sunden F, Hakansson L, Ljunggren E, Wullt B. 2006. Bacterial interference-is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection? Int J Antimicrob Agents 28(Suppl 1):S26-S29. http://dx.doi.org/10.1016/j.ijantimicag.2006.05.007.
15. Zdziarski J, Brzuszkiewicz E, Wullt B, Liesegang H, Biran D, Voigt B, Gronberg-Hernandez J, Ragnarsdottir B, Hecker M, Ron EZ, Daniel R, Gottschalk G, Hacker J, Svanborg C, Dobrindt U. 2010. Host imprints on bacterial genomes-rapid, divergent evolution in individual patients. PLoS Pathog 6:e1001078. http://dx.doi.org/10.1371/journal.ppat.1001078.
16. Klemm P, Roos V, Ulett GC, Svanborg C, Schembri MA. 2006. Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect Immun 74:781-785. http://dx.doi.org/10.1128/IAI.74.1.781-785.2006.
17. Roos V, Schembri MA, Ulett GC, Klemm P. 2006. Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae. Microbiology 152:1799-1806. http://dx.doi.org/10.1099/mic.0.28711-0.
18. Klemm P, Hancock V, Schembri MA. 2007. Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infect Immun 75:3688-3695. http://dx.doi.org/10.1128/IAI.01730-06.
19. Lutay N, Ambite I, Gronberg Hernandez J, Rydstrom G, Ragnarsdottir B, Puthia M, Nadeem A, Zhang J, Storm P, Dobrindt U, Wullt B, Svanborg C. 2013. Bacterial control of host gene expression through RNA polymerase II. J Clin Invest 123:2366-2379. http://dx.doi.org/10.1172/JCI66451.
20. Roos V, Nielsen EM, Klemm P. 2006. Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. FEMS Microbiol Lett 262:22-30. http://dx.doi.org/10.1111/j.1574-6968.2006.00355.x.
21. Mobley HL, Green DM, Trifillis AL, Johnson DE, Chippendale GR, Lockatell CV, Jones BD, Warren JW. 1990. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun 58:1281-1289.
22. Andersson P, Engberg I, Lidin-Janson G, Lincoln K, Hull R, Hull S, Svanborg C. 1991. Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun 59:2915-2921.
23. Bertani G. 1951. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol 62:293-300.
24. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66:4555-4558. http://dx.doi.org/10.1128/AEM.66.10.4555-4558.2000.
25. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
26. Hagberg L, Jodal U, Korhonen TK, Lidin-Janson G, Lindberg U, Svanborg Eden C. 1981. Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun 31:564-570.
27. Chin CS, Alexander DH, Marks P, Klammer AA, Drake J, Heiner C, Clum A, Copeland A, Huddleston J, Eichler EE, Turner SW, Korlach J. 2013. Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat Methods 10:563-569. http://dx.doi.org/10.1038/nmeth.2474.
28. Delcher AL, Salzberg SL, Phillippy AM. 2003. Using MUMmer to identify similar regions in large sequence sets. Curr Protoc Bioinformatics Chapter 10:Unit 10.3. http://dx.doi.org/10.1002/0471250953.bi1003s00.
29. Carver TJ, Rutherford KM, Berriman M, Rajandream MA, Barrell BG, Parkhill J. 2005. ACT: the Artemis Comparison Tool. Bioinformatics 21:3422-3423. http://dx.doi.org/10.1093/bioinformatics/bti553.
30. Darling AE, Mau B, Perna NT. 2010. progressive Mauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One 5:e11147. http://dx.doi.org/10.1371/journal.pone.0011147.
31. Carver T, Harris SR, Otto TD, Berriman M, Parkhill J, McQuillan JA. 2013. BamView: visualizing and interpretation of next-generation sequencing read alignments. Brief Bioinform 14:203-212. http://dx.doi.org/10.1093/bib/bbr073.
32. Flusberg BA, Webster DR, Lee JH, Travers KJ, Olivares EC, Clark TA, Korlach J, Turner SW. 2010. Direct detection of DNA methylation during single-molecule, real-time sequencing. Nat Methods 7:461-465. http://dx.doi.org/10.1038/nmeth.1459.
33. Clark TA, Murray IA, Morgan RD, Kislyuk AO, Spittle KE, Boitano M, Fomenkov A, Roberts RJ, Korlach J. 2012. Characterization of DNA methyltransferase specificities using single-molecule, real-time DNA sequencing. Nucleic Acids Res 40:e29. http://dx.doi.org/10.1093/nar/gkr1146.
34. Otto TD, Dillon GP, Degrave WS, Berriman M. 2011. RATT: Rapid Annotation Transfer Tool. Nucleic Acids Res 39:e57. http://dx.doi.org/10.1093/nar/gkq1268.
35. Aziz RK, Bartels D, Best AA, De Jongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M, Meyer F, Olsen GJ, Olson R, Osterman AL, Overbeek RA, McNeil LK, Paarmann D, Paczian T, Parrello B, Pusch GD, Reich C, Stevens R, Vassieva O, Vonstein V, Wilke A, Zagnitko O. 2008. The RAST Server: rapid annotations using subsystems technology. BMC Genomics 9:75. http://dx.doi.org/10.1186/1471-2164-9-75.
36. Alikhan NF, Petty NK, Ben Zakour NL, Beatson SA. 2011. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics 12:402. http://dx.doi.org/10.1186/1471-2164-12-402.
37. David M, Dzamba M, Lister D, Ilie L, Brudno M. 2011. SHRiMP2: sensitive yet practical SHort Read Mapping. Bioinformatics 27:1011-1012. http://dx.doi.org/10.1093/bioinformatics/btr046.
38. Stamatakis A. 2006. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 22:2688-2690. http://dx.doi.org/10.1093/bioinformatics/btl446.
39. Roos V, Ulett GC, Schembri MA, Klemm P. 2006. The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine. Infect Immun 74:615-624. http://dx.doi.org/10.1128/IAI.74.1.615-624.2006.
40. Fang G, Munera D, Friedman DI, Mandlik A, Chao MC, Banerjee O, Feng Z, Losic B, Mahajan MC, Jabado OJ, Deikus G, Clark TA, Luong K, Murray IA, Davis BM, Keren-Paz A, Chess A, Roberts RJ, Korlach J, Turner SW, Kumar V, Waldor MK, Schadt EE. 2012. Genome-wide mapping of methylated adenine residues in pathogenic Escherichia coli using single-molecule real-time sequencing. Nat Biotechnol 30:1232-1239. http://dx.doi.org/10.1038/nbt.2432.
41. Cooper KK, Mandrell RE, Louie JW, Korlach J, Clark TA, Parker CT, Huynh S, Chain PS, Ahmed S, Carter MQ. 2014. Comparative genomics of enterohemorrhagic Escherichia coli O145:H28 demonstrates a common evolutionary lineage with Escherichia coli O157:H7. BMC Genomics 15:17. http://dx.doi.org/10.1186/1471-2164-15-17.
42. Powers JG, Weigman VJ, Shu J, Pufky JM, Cox D, Hurban P. 2013. Efficient and accurate whole genome assembly and methylome profiling of E. coli. BMC Genomics 14:675. http://dx.doi.org/10.1186/1471-2164-14-675.
43. Sokurenko EV, Chesnokova V, Dykhuizen DE, Ofek I, Wu XR, Krogfelt KA, Struve C, Schembri MA, Hasty DL. 1998. Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci U S A 95:8922-8926. http://dx.doi.org/10.1073/pnas.95.15.8922.
44. Gehring AM, DeMoll E, Fetherston JD, Mori I, Mayhew GF, Blattner FR, Walsh CT, Perry RD. 1998. Iron acquisition in plague: modular logic in enzymatic biogenesis of yersiniabactin by Yersinia pestis. Chem Biol 5:573-586. http://dx.doi.org/10.1016/S1074-5521(98)90115-6.
45. Brown PK, Dozois CM, Nickerson CA, Zuppardo A, Terlonge J, Curtiss R. 2001. MlrA, a novel regulator of curli (AgF) and extracellular matrix synthesis by Escherichia coli and Salmonella enterica serovar Typhimurium. Mol Microbiol 41:349-363. http://dx.doi.org/10.1046/j.1365-2958.2001.02529.x.
46. Vejborg RM, Friis C, Hancock V, Schembri MA, Klemm P. 2010. A virulent parent with probiotic progeny: comparative genomics of Escherichia coli strains CFT073, Nissle 1917 and ABU 83972. Mol Genet Genomics 283:469-484. http://dx.doi.org/10.1007/s00438-010-0532-9.
47. Hochhut B, Wilde C, Balling G, Middendorf B, Dobrindt U, Brzuszkiewicz E, Gottschalk G, Carniel E, Hacker J. 2006. Role of pathogenicity island-associated integrases in the genome plasticity of uropathogenic Escherichia coli strain 536. Mol Microbiol 61:584-595. http://dx.doi.org/10.1111/j.1365-2958.2006.05255.x.
48. Grozdanov L, Raasch C, Schulze J, Sonnenborn U, Gottschalk G, Hacker J, Dobrindt U. 2004. Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol 186:5432-5441. http://dx.doi.org/10.1128/JB.186.16.5432-5441.2004.
49. Touchon M, Hoede C, Tenaillon O, Barbe V, Baeriswyl S, Bidet P, Bingen E, Bonacorsi S, Bouchier C, Bouvet O, Calteau A, Chiapello H, Clermont O, Cruveiller S, Danchin A, Diard M, Dossat C, Karoui ME, Frapy E, Garry L, Ghigo JM, Gilles AM, Johnson J, Le Bouguenec C, Lescat M, Mangenot S, Martinez-Jehanne V, Matic I, Nassif X, Oztas S, Petit MA, Pichon C, Rouy Z, Ruf CS, Schneider D, Tourret J, Vacherie B, Vallenet D, Medigue C, Rocha EP, Denamur E. 2009. Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet 5:e1000344. http://dx.doi.org/10.1371/journal.pgen.1000344.
50. Rumer L, Jores J, Kirsch P, Cavignac Y, Zehmke K, Wieler LH. 2003. Dissemination of pheU- and pheV-located genomic islands among enteropathogenic (EPEC) and enterohemorrhagic (EHEC) E. coli and their possible role in the horizontal transfer of the locus of enterocyte effacement (LEE). Int J Med Microbiol 292:463-475. http://dx.doi.org/10.1078/1438-4221-00229.
51. Tauschek M, Strugnell RA, Robins-Browne RM. 2002. Characterization and evidence of mobilization of the LEE pathogenicity island of rabbitspecific strains of enteropathogenic Escherichia coli. Mol Microbiol 44:1533-1550. http://dx.doi.org/10.1046/j.1365-2958.2002.02968.x.
52. Lalioui L, Le Bouguenec C. 2001. afa-8 Gene cluster is carried by a pathogenicity island inserted into the tRNA(Phe) of human and bovine pathogenic Escherichia coli isolates. Infect Immun 69:937-948. http://dx.doi.org/10.1128/IAI.69.2.937-948.2001.
53. Johnson TJ, Kariyawasam S, Wannemuehler Y, Mangiamele P, Johnson SJ, Doetkott C, Skyberg JA, Lynne AM, Johnson JR, Nolan LK. 2007. The genome sequence of avian pathogenic Escherichia coli strain O1: K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes. J Bacteriol 189:3228-3236. http://dx.doi.org/10.1128/JB.01726-06.
54. Middendorf B, Hochhut B, Leipold K, Dobrindt U, Blum-Oehler G, Hacker J. 2004. Instability of pathogenicity islands in uropathogenic Escherichia coli 536. J Bacteriol 186:3086-3096. http://dx.doi.org/10.1128/JB.186.10.3086-3096.2004.
55. Korotkova N, Chattopadhyay S, Tabata TA, Beskhlebnaya V, Vigdorovich V, Kaiser BK, Strong RK, Dykhuizen DE, Sokurenko EV, Moseley SL. 2007. Selection for functional diversity drives accumulation of point mutations in Dr adhesins of Escherichia coli. Mol Microbiol 64:180-194. http://dx.doi.org/10.1111/j.1365-2958.2007.05648.x.
56. Valle J, Mabbett AN, Ulett GC, Toledo-Arana A, Wecker K, Totsika M, Schembri MA, Ghigo JM, Beloin C. 2008. Upa G, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli. J Bacteriol 190:4147-4161. http://dx.doi.org/10.1128/JB.00122-08.
57. Ulett GC, Valle J, Beloin C, Sherlock O, Ghigo JM, Schembri MA. 2007. Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun 75:3233-3244. http://dx.doi.org/10.1128/IAI.01952-06.
58. Lloyd AL, Rasko DA, Mobley HL. 2007. Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol 189:3532-3546. http://dx.doi.org/10.1128/JB.01744-06.
59. Hacker J, Kaper JB. 2000. Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol 54:641-679. http://dx.doi.org/10.1146/annurev.micro.54.1.641.
60. Petty NK, Ben Zakour NL, Stanton-Cook M, Skippington E, Totsika M, Forde BM, Phan MD, Gomes Moriel D, Peters KM, Davies M, Rogers BA, Dougan G, Rodriguez-Bano J, Pascual A, Pitout JD, Upton M, Paterson DL, Walsh TR, Schembri MA, Beatson SA. 2014. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A 111:5694-5699. http://dx.doi.org/10.1073/pnas.1322678111.
61. Jores J, Rumer L, Kiessling S, Kaper JB, Wieler LH. 2001. A novel locus of enterocyte effacement (LEE) pathogenicity island inserted at pheV in bovine Shiga toxin-producing Escherichia coli strain O103: H2. FEMS Microbiol Lett 204:75-79. http://dx.doi.org/10.1111/j.1574-6968.2001.tb10866.x.
62. Braun V. 2003. Iron uptake by Escherichia coli. Front Biosci 8:s1409-s1421. http://dx.doi.org/10.2741/1232.
63. Watts RE, Totsika M, Challinor VL, Mabbett AN, Ulett GC, De Voss JJ, Schembri MA. 2012. Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli. Infect Immun 80:333-344. http://dx.doi.org/10.1128/IAI.05594-11.
64. Torres AG, Redford P, Welch RA, Payne SM. 2001. TonB-dependent systems of uropathogenic Escherichia coli: aerobactin and heme transport and TonB are required for virulence in the mouse. Infect Immun 69:6179-6185. http://dx.doi.org/10.1128/IAI.69.10.6179-6185.2001.
65. Roos V, Klemm P. 2006. Global gene expression profiling of the asymptomatic bacteriuria Escherichia coli strain 83972 in the human urinary tract. Infect Immun 74:3565-3575. http://dx.doi.org/10.1128/IAI.01959-05.
66. Schwyn B, Neilands JB. 1987. Universal chemical assay for the detection and determination of siderophores. Anal Biochem 160:47-56. http://dx.doi.org/10.1016/0003-2697(87)90612-9.
67. Garcia MI, Gounon P, Courcoux P, Labigne A, Le Bouguenec C. 1996. The afimbrial adhesive sheath encoded by the afa-3 gene cluster of pathogenic Escherichia coli is composed of two adhesins. Mol Microbiol 19:683-693. http://dx.doi.org/10.1046/j.1365-2958.1996.394935.x.
68. Labigne-Roussel A, Schmidt MA, Walz W, Falkow S. 1985. Genetic organization of the afimbrial adhesin operon and nucleotide sequence from a uropathogenic Escherichia coli gene encoding an afimbrial adhesin. J Bacteriol 162:1285-1292.
69. Labigne-Roussel AF, Lark D, Schoolnik G, Falkow S. 1984. Cloning and expression of an afimbrial adhesin (AFA-I) responsible for P blood groupindependent, mannose-resistant hemagglutination from a pyelonephritic Escherichia coli strain. Infect Immun 46:251-259.
70. Lalioui L, Jouve M, Gounon P, Le Bouguenec C. 1999. Molecular cloning and characterization of the afa-7 and afa-8 gene clusters encoding afimbrial adhesins in Escherichia coli strains associated with diarrhea or septicemia in calves. Infect Immun 67:5048-5059.
71. Le Bouguenec C, Garcia MI, Ouin V, Desperrier JM, Gounon P, Labigne A. 1993. Characterization of plasmid-borne afa-3 gene clusters encoding afimbrial adhesins expressed by Escherichia coli strains associated with intestinal or urinary tract infections. Infect Immun 61:5106-5114.
72. Nowicki B, Barrish JP, Korhonen T, Hull RA, Hull SI. 1987. Molecular cloning of the Escherichia coli O75X adhesin. Infect Immun 55:3168-3173.
73. Pham TQ, Goluszko P, Popov V, Nowicki S, Nowicki BJ. 1997. Molecular cloning and characterization of Dr-II, a nonfimbrial adhesin-I-like adhesin isolated from gestational pyelonephritis-associated Escherichia coli that binds to decay-accelerating factor. Infect Immun 65:4309-4318.
74. Bilge SS, Apostol JM, Jr, Fullner KJ, Moseley SL. 1993. Transcriptional organization of the F1845 fimbrial adhesin determinant of Escherichia coli. Mol Microbiol 7:993-1006. http://dx.doi.org/10.1111/j.1365-2958.1993.tb01191.x.
75. Bilge SS, Clausen CR, Lau W, Moseley SL. 1989. Molecular characterization of a fimbrial adhesin, F1845, mediating diffuse adherence of diarrhea-associated Escherichia coli to HEp-2 cells. J Bacteriol 171:4281-4289.
76. Servin AL. 2005. Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Clin Microbiol Rev 18:264-292. http://dx.doi.org/10.1128/CMR.18.2.264-292.2005.
77. Servin AL. 2014. Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges. Clin Microbiol Rev 27:823-869. http://dx.doi.org/10.1128/CMR.00036-14.
78. Nowicki B, Hart A, Coyne KE, Lublin DM, Nowicki S. 1993. Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction. J Exp Med 178:2115-2121. http://dx.doi.org/10.1084/jem.178.6.2115.
79. Medof ME, Walter EI, Rutgers JL, Knowles DM, Nussenzweig V. 1987. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med 165:848-864. http://dx.doi.org/10.1084/jem.165.3.848.
80. Korotkova N, Cota E, Lebedin Y, Monpouet S, Guignot J, Servin AL, Matthews S, Moseley SL. 2006. A subfamily of Dr adhesins of Escherichia coli bind independently to decay-accelerating factor and the N-domain of carcinoembryonic antigen. J Biol Chem 281:29120-29130. http://dx.doi.org/10.1074/jbc.M605681200.
81. Berger CN, Billker O, Meyer TF, Servin AL, Kansau I. 2004. Differential recognition of members of the carcinoembryonic antigen family by Afa/Dr adhesins of diffusely adhering Escherichia coli (Afa/Dr DAEC). Mol Microbiol 52:963-983. http://dx.doi.org/10.1111/j.1365-2958.2004.04033.x.
82. Rana T, Hasan RJ, Nowicki S, Venkatarajan MS, Singh R, Urvil PT, Popov V, Braun WA, Popik W, Goodwin JS, Nowicki BJ. 2014. Complement protective epitopes and CD55-microtubule complexes facilitate the invasion and intracellular persistence of uropathogenic Escherichia coli. J Infect Dis 209:1066-1076. http://dx.doi.org/10.1093/infdis/jit619.
83. Goluszko P, Popov V, Selvarangan R, Nowicki S, Pham T, Nowicki BJ. 1997. Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. J Infect Dis 176:158-167. http://dx.doi.org/10.1086/514018.
84. Bokil NJ, Totsika M, Carey AJ, Stacey KJ, Hancock V, Saunders BM, Ravasi T, Ulett GC, Schembri MA, Sweet MJ. 2011. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages. Immunobiology 216:1164-1171. http://dx.doi.org/10.1016/j.imbio.2011.05.011.
85. Tree JJ, Ulett GC, Ong CL, Trott DJ, McEwan AG, Schembri MA. 2008. Trade-off between iron uptake and protection against oxidative stress: deletion of cueO promotes uropathogenic Escherichia coli virulence in a mouse model of urinary tract infection. J Bacteriol 190:6909-6912. http://dx.doi.org/10.1128/JB.00451-08.
86. Wullt B, Bergsten G, Connell H, Rollano P, Gebratsedik N, Hang L, Svanborg C. 2001. P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract. Cell Microbiol 3:255-264. http://dx.doi.org/10.1046/j.1462-5822.2001.00111.x.
87. Svanborg C, Frendeus B, Godaly G, Hang L, Hedlund M, Wachtler C. 2001. Toll-like receptor signaling and chemokine receptor expression influence the severity of urinary tract infection. J Infect Dis 183(Suppl 1): S61-S65. http://dx.doi.org/10.1086/318858.
88. Bergsten G, Wullt B, Schembri MA, Leijonhufvud I, Svanborg C. 2007. Do type 1 fimbriae promote inflammation in the human urinary tract? Cell Microbiol 9:1766-1781. http://dx.doi.org/10.1111/j.1462-5822.2007.00912.x.
89. Gronberg-Hernandez J, Sunden F, Connolly J, Svanborg C, Wullt B. 2011. Genetic control of the variable innate immune response to asymptomatic bacteriuria. PLoS One 6:e28289. http://dx.doi.org/10.1371/journal.pone.0028289.
90. Ragnarsdottir B, Fischer H, Godaly G, Gronberg-Hernandez J, Gustafsson M, Karpman D, Lundstedt AC, Lutay N, Ramisch S, Svensson ML, Wullt B, Yadav M, Svanborg C. 2008. TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections. Eur J Clin Invest 38(Suppl 2):S12-S20. http://dx.doi.org/10.1111/j.1365-2362.2008.02004.x.
91. Ragnarsdottir B, Jonsson K, Urbano A, Gronberg-Hernandez J, Lutay N, Tammi M, Gustafsson M, Lundstedt AC, Leijonhufvud I, Karpman D, Wullt B, Truedsson L, Jodal U, Andersson B, Svanborg C. 2010. Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PLoS One 5:e10734. http://dx.doi.org/10.1371/journal.pone.0010734.
92. Ragnarsdottir B, Lutay N, Gronberg-Hernandez J, Koves B, Svanborg C. 2011. Genetics of innate immunity and UTI susceptibility. Nat Rev Urol 8:449-468. http://dx.doi.org/10.1038/nrurol.2011.100.
93. Ragnarsdottir B, Samuelsson M, Gustafsson MC, Leijonhufvud I, Karpman D, Svanborg C. 2007. Reduced Toll-like receptor 4 expression in children with asymptomatic bacteriuria. J Infect Dis 196:475-484. http://dx.doi.org/10.1086/518893.
94. Hart A, Nowicki BJ, Reisner B, Pawelczyk E, Goluszko P, Urvil P, Anderson G, Nowicki S. 2001. Ampicillin-resistant Escherichia coli in gestational pyelonephritis: increased occurrence and association with the colonization factor Dr adhesin. J Infect Dis 183:1526-1529. http://dx.doi.org/10.1086/320196.
95. Goluszko P, Moseley SL, Truong LD, Kaul A, Williford JR, Selvarangan R, Nowicki S, Nowicki B. 1997. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. J Clin Invest 99:1662-1672. http://dx.doi.org/10.1172/JCI119329.
96. Foxman B, Zhang L, Tallman P, Palin K, Rode C, Bloch C, Gillespie B, Marrs CF. 1995. Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection. J Infect Dis 172:1536-1541. http://dx.doi.org/10.1093/infdis/172.6.1536.